Research Roundup: June 9, 2026

Best of cannabinoid science this week...

For the agitation of Alzheimer's disease, a meta-analysis of 7 studies found cannabinoids lowered neuropsychiatric symptoms & agitation scores

Cannabinoids Treatment for Agitation in Alzheimer’s Disease: A Systematic Review and Meta-Analysis with Bayesian and Sequential Trial Analyses

https://www.ajgponline.org/article/S1064-7481(26)00400-8/abstract

For neuropathic pain from a spinal cord injury, a trial of high-dose CBD isolate found it significantly reduced the self-reported intensity of neuropathic pain & was generally well tolerated

High-dose cannabidiol for chronic neuropathic pain associated with spinal cord injury: a randomised clinical trial

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(26)00234-8/fulltext

In children with autism, CBD isolate improved irritability, tantrums, restricted & repetitive behaviors, sociality, anxiety & sleep problems

A Phase-2 Open-Label Trial of Cannabidiol to Treat Core and Associated Symptoms of Autism in Children and Adolescents Without Intellectual Disability

https://journals.sagepub.com/doi/abs/10.1177/10445463261452514

For chronic pain from hypermobility, a case series from the UK Medical Cannabis Registry found that the initiation of cannabis-based medicines improved all patient-reported outcomes with significant improvements in pain severity & interference

UK Medical Cannabis Registry: an updated analysis of clinical outcomes of medicinal cannabis therapy for hypermobility-associated chronic pain

https://link.springer.com/article/10.1007/s10067-026-08166-z

For severe, drug-resistant pediatric epilepsies, a meta-analysis of 46 studies found CBD reduced seizures in ~ half of patients

Cannabidiol Use in Developmental and Epileptic Encephalopathies: A Syndrome- and Age-Stratified Systematic Review and Meta-analysis

https://link.springer.com/article/10.1007/s40263-026-01301-z

In people with cancer using cannabis for their symptoms, more than half reported significant relief across all symptom domains

Association of iterative cannabis care plans with rates of symptom relief and side effect burden in oncology patients

https://ascopubs.org/doi/abs/10.1200/JCO.2026.44.16_suppl.12070

For cancer survivors using CBD, a survey found that they used it for pain, insomnia, stress, depression & neuropathy

Cannabidiol and Cancer Survivors: Utilization and Experiences

https://journals.sagepub.com/doi/abs/10.1177/10966218261448666

For people with cancer, one-third of them used cannabis for symptom management & their household income & neighborhood disadvantage caused different effects on the help for their pain, sleep & anxiety

Associations between neighborhood disadvantage, cannabis use, and patient-reported outcomes among patients with cancer

https://www.sciencedirect.com/science/article/pii/S2772724626000429

For cannabis use & PTSD symptoms in combat veterans, this thesis project hypothesized that decreased use would improve mental health outcomes but in fact, "decreased cannabis use was associated with worsening PTSD symptoms, reduced quality of life, and decreased satisfaction with concentration"

Effects of Cannabis Use Reduction on PTSD Symptoms in Combat Veterans: An Ecological Momentary Assessment Study

https://www.proquest.com/openview/14beb7335d6ffca4d4a4356b09e3c76e/1?pq-origsite=gscholar&cbl=18750&diss=y

For CBD & the mucosa (linings of the insides of organs & body cavities), a review on CBD for targeting a range of diseases (good charts)

Cannabidiol for Mucosal Diseases: Therapeutic Potential and Advanced Delivery Strategies

https://www.mdpi.com/1999-4923/18/6/638

In a mouse model of cognitive decline from chemotherapy, one month of CBD caused significant neurocognitive improvements in learning, memory, executive function & memory consolidation while mitigating the loss of neuronal plasticity, synaptic density & neurogenesis (the birth of new brain cells)

Cannabidiol alleviates chemotherapy-induced cognitive decline and neuropathology

https://www.sciencedirect.com/science/article/pii/S0304383526003757

In rats taking oxycodone for pain, CBD enhanced the painkilling effect without increasing the symptoms of addiction

Selective opioid-sparing effects of cannabidiol on opioid analgesia in rats

https://www.jpain.org/article/S1526-5900(26)00156-2/abstract

In a mouse model of age-related muscle decline, CBD reduced inflammation, oxidative stress, DNA damage & muscle aging with benefits for the gut microbiome

Cannabidiol alleviates D-galactose-induced muscle tissue aging in mice by modulating oxidative stress and is associated with alterations in gut microbiota

https://www.sciencedirect.com/science/article/abs/pii/S2212429226008990

For bacteria resistant to antibiotics, the combination of CBD & the antibiotic diclofenac caused synergistic & additive effects

Combining Diclofenac and Cannabidiol to Enhance the Antibacterial Capacity of Nonantibiotics Drugs Through Potentiation

https://www.preprints.org/frontend/manuscript/928f120ab7cb59f7635e6a868a6aac24/download_pub

In a tissue model of diabetes, THC, CBG & CBD inhibited the enzyme α-glucosidase (helps with control of type 2 diabetes)

Potent α-Glucosidase Inhibition by a Non-Psychoactive CBG/CBD-Rich Cannabis Extract

https://openurl.ebsco.com/EPDB%3Agcd%3A1%3A31129329/detailv2?sid=ebsco%3Aplink%3Acrawler-gcd&id=ebsco%3Agcd%3A193898239&crl=c&jrnl=26160684&link_origin=none